InspireMD (NSPR) FCF Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 112,225.00 |
| Sep 30, 2025 | -4,460.00 |
| Jun 30, 2025 | -2,727.00 |
| Mar 31, 2025 | -37,084.00 |
| Dec 31, 2024 | -20,227.00 |
| Sep 30, 2024 | -13,306.00 |
| Jun 30, 2024 | -5,642.00 |
| Mar 31, 2024 | 50,762.00 |
| Dec 31, 2023 | -2,556.00 |
| Sep 30, 2023 | -2,790.00 |
| Jun 30, 2023 | 1,707.00 |
| Mar 31, 2023 | -21,507.00 |
| Dec 31, 2022 | -10,532.00 |
| Sep 30, 2022 | -8,263.00 |
| Jun 30, 2022 | 3,957.00 |
| Mar 31, 2022 | 15,902.00 |
| Dec 31, 2021 | 37,737.00 |
| Sep 30, 2021 | 22,928.00 |
| Jun 30, 2021 | -10,171.00 |
| Mar 31, 2021 | -3,325.00 |
| Dec 31, 2020 | -100,122.00 |
| Jun 30, 2020 | -12,008.00 |
| Mar 31, 2019 | -60,452.00 |
| Sep 30, 2018 | -2,212.00 |
| Jun 30, 2018 | 8,630.00 |
| Mar 31, 2018 | 1,125.00 |
| Dec 31, 2017 | 4,354.00 |
| Sep 30, 2017 | 17,991.00 |
| Mar 31, 2017 | -36,591.00 |
| Dec 31, 2016 | -26,144.00 |
| Sep 30, 2016 | -52,369.00 |
| Jun 30, 2016 | -867.00 |
| Mar 31, 2016 | -30,819.00 |
| Dec 31, 2015 | -35,095.00 |